Composite risk and benefit from adjuvant dose-dense chemotherapy in hormone receptor-positive breast cancer

Fabio Puglisi, Lorenzo Gerratana, Matteo Lambertini, Marcello Ceppi, Luca Boni, Filippo Montemurro, Stefania Russo, Claudia Bighin, Michelino De Laurentiis, Mario Giuliano, Giancarlo Bisagni, Antonio Durando, Anna Turletti, Ornella Garrone, Andrea Ardizzoni, Teresa Gamucci, Giuseppe Colantuoni, Adriano Gravina, Sabino De Placido, Francesco CognettiLucia Del Mastro

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Composite risk and benefit from adjuvant dose-dense chemotherapy in hormone receptor-positive breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences